Source link : https://newshealth.biz/health-news/sglt2-inhibitor-shows-promise-as-mash-treatment/
(MedPage Today) — An SGLT2 inhibitor helped improve metabolic dysfunction-associated steatohepatitis (MASH) in people with or without type 2 diabetes, a randomized trial in China found. In 154 adults with biopsy-diagnosed MASH, improvement without… Source link : https://www.medpagetoday.com/gastroenterology/generalhepatology/115913 Author : Publish date : 2025-06-04 22:30:00 Copyright for syndicated content belongs to the linked Source.
The post SGLT2 Inhibitor Shows Promise as MASH Treatment first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-04 22:30:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8